Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

997
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
997
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

789
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
789

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De novo design of miniproteins targeting GPCRs.

Nature·2026
Same author

[Late complications after atrial fibrillation ablation : Diagnosis and management].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same author

Progress in Designing Cytokine Antagonist Antibodies for Cancer Therapy.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same author

Miniaturized IL-2/anti-IL-2 immunocytokines selectively activate and support the <i>in vivo</i> persistence of regulatory T cells.

Frontiers in immunology·2026
Same author

The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

bioRxiv : the preprint server for biology·2026
Same author

Dynamics and variegation in the Treg response to Interleukin-2.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Jul 6, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

10.5K

Engineering Anticytokine Antibodies for Immune Modulation.

Jakub Tomala1,2, Shanelle D Cao1,2, Jamie B Spangler1,2,3,4,5,6,7,8

  • 1Department of Chemical & Biomolecular Engineering, Johns Hopkins University School of Engineering, Baltimore, MD.

Journal of Immunology (Baltimore, Md. : 1950)
|January 2, 2024
PubMed
Summary

Harnessing cytokine drugs for diseases like cancer is promising but challenging. Anticytokine antibodies offer a novel strategy to enhance cytokine therapy efficacy and safety.

More Related Videos

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

6.9K
Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.1K

Related Experiment Videos

Last Updated: Jul 6, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

10.5K
Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

6.9K
Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.1K

Area of Science:

  • Immunology
  • Pharmacology
  • Biotechnology

Background:

  • Immune homeostasis relies on cytokine-receptor interactions.
  • Cytokines show therapeutic potential for cancer and autoimmune diseases.
  • Cytokine therapies face challenges like short half-lives and toxicity.

Approach:

  • Developing anticytokine antibodies to improve cytokine drug delivery.
  • Utilizing antibodies to extend cytokine circulation and enhance selectivity.
  • Focusing on agonistic anticytokine antibodies for targeted therapy.

Key Points:

  • Anticytokine antibodies can prolong cytokine half-life.
  • These antibodies can selectively modulate cytokine immune activity.
  • The review highlights agonistic, not antagonistic, antibody functions.
  • This approach aims to overcome limitations of current cytokine therapies.

Conclusions:

  • Anticytokine antibodies represent a promising strategy for cytokine-based therapeutics.
  • This approach could unlock the clinical potential of cytokine therapies.
  • Enhanced selectivity and safety are key benefits of this method.